Project Details
Description
Pilot Analysis of unbound sorafenib: relevance to efficacy and toxicity in a Phase I trial and to in-vitro cytotoxicity
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/12 → 10/31/14 |
Funding
- MN MED FDN
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.